Skip to main content
SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. logo

SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. — Investor Relations & Filings

Ticker · 688238 ISIN · CNE1000059N9 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 486 across all filing types
Latest filing 2023-06-28 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 688238

About SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD.

https://www.obio-tech.com/

SHANGHAI OBIO TECHNOLOGY (GROUP) CORP., LTD. is a specialized Contract Development and Manufacturing Organization (CDMO) focused on the gene and cell therapy (GCT) sector. The company provides end-to-end solutions encompassing vector construction, process development, analytical method development, and large-scale GMP manufacturing. Its service portfolio includes the production of viral vectors such as adeno-associated virus (AAV), lentivirus, adenovirus, and oncolytic viruses, as well as plasmid DNA and cell therapy products. Obio Technology supports clients from early-stage research through clinical trials to commercialization. The company operates advanced facilities designed to meet international regulatory standards, facilitating the development of innovative genetic medicines and advanced therapies for global biopharmaceutical partners.

Recent filings

Filing Released Lang Actions
关于调整2021年股票期权激励计划行权价格及期权数量的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding adjustments to its 2021 stock option incentive plan, specifically changes to the exercise price and the number of stock options. It details the approval process, legal opinions, and the rationale behind the adjustments. The content focuses on corporate governance and management decisions related to stock options rather than financial results or earnings. It is not a full financial report, earnings release, or regulatory filing of financial data. The document is a formal announcement of changes in the stock option plan, which is a capital structure related update. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is under 5,000 characters, but it contains substantive information about the adjustment, not just a notice of report publication or certification, so it is not RPA or RNS.
2023-06-28 Chinese
第三届董事会第八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the eighth meeting of the third board of directors of Heyuan Biotech (Shanghai) Co., Ltd. It details the meeting date, attendance, and specific board decisions such as adjustments to the stock option plan, changes in registered capital, amendments to the company charter, and the proposal to convene an extraordinary general meeting. The document does not contain financial statements or detailed financial data but rather reports on board meeting decisions and related corporate governance matters. It also references other announcements published separately on the stock exchange website. Therefore, this document fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the company's board of directors or senior management.
2023-06-28 Chinese
关于召开2023年第一次临时股东大会的通知
Regulatory Filings Classification · 95% confidence The document is a notice about convening the 2023 first extraordinary general meeting of shareholders (临时股东大会) for the company 和元生物技术（上海）股份有限公司. It details the meeting date, voting methods, agenda items, registration procedures, and proxy authorization. There is no financial data, earnings, audit information, or report content. It is an announcement related to a shareholder meeting, specifically a notice to shareholders about the meeting and voting procedures. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is a notice of the meeting and voting procedures rather than the solicitation materials or proxy statement, it is best classified as a Regulatory Filing (RNS) as a fallback for miscellaneous regulatory announcements that do not fit other categories. The document length is short (3105 characters), and it is not a report or presentation but a formal meeting notice.
2023-06-28 Chinese
上海市金茂律师事务所关于和元生物技术（上海）股份有限公司调整2021年股票期权激励计划行权价格及期权数量之法律意见书
Regulatory Filings
2023-06-28 Chinese
关于变更公司注册资本及修订公司章程并办理工商变更登记的公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from a company about changes to its registered capital and amendments to its articles of association, including details of share capital increase and related corporate governance document revisions. It mentions board resolutions and upcoming shareholder meeting approval but does not contain full financial statements or detailed financial performance data. The document is relatively short (1480 characters) and serves as a formal notice of corporate capital change and related filings rather than a full report or financial statement. This fits the category of Share Issue/Capital Change announcements rather than an Annual Report, Interim Report, or Regulatory Filing. Therefore, the appropriate classification is 'SHA' (Share Issue/Capital Change).
2023-06-28 Chinese
独立董事关于第三届董事会第八次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors regarding the adjustment of the 2021 stock option incentive plan's exercise price and quantity. It references the company's board meeting and legal compliance but does not contain financial statements or detailed financial data. The document is short (517 characters) and focuses on governance and approval of stock option adjustments, which relates to management or board information rather than a full report or announcement of voting results. Therefore, it fits best under Board/Management Information (MANG).
2023-06-28 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.